Volume 30, Number 5—May 2024
Research
SARS-CoV-2 Transmission in Alberta, British Columbia, and Ontario, Canada, January 2020–January 2022
Table 2
Category | Alberta | British Columbia | Ontario | Overall |
---|---|---|---|---|
Population size, 2021 |
4,262,635 |
5,000,879 |
14,223,942 |
23,487,456 |
No. days observed | ||||
Variant | ||||
Wild-type | 562 | 573 | 572 | Not applicable |
Alpha | 602 | 602 | 602 | Not applicable |
Delta | 460 | 460 | 460 | Not applicable |
Omicron |
68 |
68 |
68 |
Not applicable |
Cumulative case count | ||||
Variant | ||||
Wild-type | 146,910 | 91,170 | 337,299 | 575,379 |
Alpha | 54,621 | 36,951 | 133,162 | 224,734 |
Delta | 116,902 | 82,441 | 121,710 | 321,053 |
Omicron | 141,661 | 91,491 | 366,495 | 599,646 |
Total (%) |
460,094 (26.74) |
302,053 (17.55) |
958,666 (55.71) |
1,720,812 (100) |
Cumulative case count per 100,000 person-days | ||||
Variant | ||||
Wild-type | 6.13 | 3.18 | 4.15 | 4.29 |
Alpha | 2.13 | 1.23 | 1.56 | 1.59 |
Delta | 5.96 | 3.58 | 1.86 | 2.97 |
Omicron | 48.87 | 26.90 | 37.89 | 37.54 |
Total |
6.38 |
3.45 |
3.96 |
4.31 |
IRR between variant by province | ||||
Variant | ||||
Wild-type (95% CI) | Referent | Referent | Referent | Referent |
Alpha (95% CI) | 0.347 (0.344–0.351)† | 0.386 (0.381–0.390)† | 0.375 (0.373–0.378)† | 0.370 (0.368–0.372)† |
Delta (95% CI) | 0.972 (0.965–0.980)† | 1.126 (1.116–1.137)† | 0.449 (0.446–0.452)† | 0.692 (0.689–0.695)† |
Omicron (95% CI) |
7.969 (7.911–8.028)† |
8.456 (8.379–8.534)† |
9.140 (9.097–9.183)† |
8.742 (8.710–8.774)† |
IRR between province by variant | ||||
Variant | ||||
Wild-type (95% CI) | 1.927 (1.912–1.943)† | Referent | 1.303 (1.294–1.313)† | Not applicable |
Alpha (95% CI) | 1.734 (1.711–1.757)† | Referent | 1.267 (1.252–1.282)† | Not applicable |
Delta (95% CI) | 1.664 (1.649–1.678)† | Referent | 0.519 (0.514–0.524)† | Not applicable |
Omicron (95% CI) | 1.827 (1.801–1.832)† | Referent | 1.408 (1.398–1.419)† | Not applicable |
Overall (95% CI) | 1.799 (1.790–1.807)† | Referent | 1.117 (1.112–1.121)† | Not applicable |
*IRR, incidence rate ratio. †p<0.0001.
1These first authors contributed equally to this article.
2These second authors contributed equally to this article.
Page created: February 29, 2024
Page updated: April 25, 2024
Page reviewed: April 25, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.